行情

SENS

SENS

Senseonics控股
AMEX

实时行情|Nasdaq Last Sale

3.570
-0.160
-4.29%
盘后: 3.610 +0.04 +1.12% 19:59 09/24 EDT
开盘
3.630
昨收
3.730
最高
3.680
最低
3.560
成交量
675.42万
成交额
--
52周最高
5.56
52周最低
0.3497
市值
15.90亿
市盈率(TTM)
-2.2221
分时
5日
1月
3月
1年
5年
尽管大流行得到控制,对消毒产品的需求仍在继续增长
/PRNewswire/ -- The economy has shown signs of recovery, but fears related to the pandemic and its new variants remain. Last year, the World Health Organization (WHO) published a list of medical devices required, broken down into several categories includi...
PR Newswire - PRF · 3天前
颗粒物传感器市场-全球规模、增长洞察力、份额、趋势、行业主要参与者、到 2029 年的区域预测
Research Nester released a report titled ": Global Demand Analysis & Opportunity Outlook 2029"which delivers detailed overview of the global particulate matter sensor market in terms of market segmentation by type, end user and region.
AmericaNewsHour · 4天前
Senseonics 低于 4 美元吗?
StockNews.com · 09/16 08:44
Senseonics 的血糖监测系统将提供给俄亥俄州克利夫兰的大学医院责任医疗组织的医疗保险成员
MT Newswires · 09/14 04:51
Senseonics 宣布与俄亥俄州克利夫兰的大学医院责任医疗组织合作
Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system for people with
Benzinga · 09/13 20:06
Senseonics 宣布与俄亥俄州克利夫兰的大学医院责任医疗组织 (UHACO) 合作
GERMANTOWN, Md., September 13, 2021--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system for ...
Business Wire · 09/13 20:05
Senseonics 将参加 HC Wainwright 全球投资大会
GERMANTOWN, Md., September 09, 2021--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabet...
Business Wire · 09/09 22:59
从令人失望的第二季度反弹后,Senseonic 股票正在攀升
Investor Place · 09/02 10:00
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解SENS最新的财务预测,通过SENS每股收益,每股净资产,每股现金流等数据分析Senseonics控股近期的经营情况,然后做出明智的投资选择。
分析师评级

8位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测SENS价格均价为3.460,最高价位6.00,最低价为0.8000。
EPS
机构持股
总机构数: 117
机构持股: 9,351.57万
持股比例: 21.00%
总股本: 4.45亿
类型机构数股数
增持
49
473.54万
建仓
13
327.83万
减持
18
536.59万
平仓
21
158.19万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
医疗设备、用品及经销
-0.61%
医疗设备和用品
-0.42%
高管信息
Chairman/Independent Director
Stephen DeFalco
President/Chief Executive Officer/Director
Timothy Goodnow
Chief Financial Officer/Treasurer/Secretary
Nick Tressler
Chief Operating Officer
Mukul Jain
Vice President/General Manager
Mirasol Panlilio
General Counsel
Kenneth Horton
Other/Director
Francine Kaufman
Director
John Marotta
Director
Robert Schumm
Independent Director
Steven Edelman
Independent Director
Edward Fiorentino
Independent Director
Douglas Prince
Independent Director
Anthony Raab
Independent Director
Douglas Roeder
暂无数据
SENS 简况
Senseonics Holdings, Inc. is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes. The Company's Eversense system consists of components, such as a sensor, which is inserted subcutaneously in the upper arm by a healthcare provider; an external removable smart transmitter that receives, assesses and relays the data from the sensor and also provides vibratory alerts, and a mobile application that receives data from the transmitter and provides real-time glucose readings, alerts and other data on the user's mobile device, such as a smartphone, Apple Watch or tablet.

微牛提供Senseonics Holdings Inc(AMEX-SENS)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的SENS股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易SENS股票基本功能。